« Back
Home /
BAY-091

BAY-091

Item no.	HY-139868-10mg
Manufacturer	MedChem Express
CASRN	2922280-34-8
Amount	10 mg
Quantity options	100 mg 10 mM/1 mL 10 mg 1 ea 25 mg 50 mg 5 mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Purity	98.45
Citations	[1]Wortmann L, et al. Discovery and Characterization of the Potent and Highly Selective 1,7-Naphthyridine-Based Inhibitors BAY-091 and BAY-297 of the Kinase PIP4K2A. J Med Chem. 2021 Nov 11;64(21):15883-15911.\|[2]Souza G F, et al. TARGETING GAMMA GLOBIN SYNTHESIS: THE ACUTE EFFECTS OF PIPKIIA INHIBITION AND PTDIN5P STIMULATION IN MYELOID CELL LINES K562 AND KU812[J]. Hematology, Transfusion and Cell Therapy, 2024, 46: S62.
Smiles	CC[C@@H](NC1=C(C#N)C(C2=CC=C(C3=CC=CC(C)=C3F)C=C2)=NC4=CN=CC=C14)C(O)=O
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Shipping Condition	Room temperature
Available
Manufacturer - Type	Reference compound
Manufacturer - Applications	Cancer-Kinase/protease
Manufacturer - Targets	PI5P4K
Shipping Temperature	Room Temperature
Storage Conditions	-20°C, 3 years; 4°C, 2 years (Powder)
Molecular Weight	440.47
Product Description	BAY-091 is a novel potent and highly selective inhibitor of the kinase PIP4K2A.
Manufacturer - Research Area	Cancer
Solubility	DMSO: 125 mg/mL (ultrasonic)
Manufacturer - Pathway	Metabolic Enzyme/Protease
Clinical information	No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-139868-10mg-safety-datasheet.pdf